Centiva Capital, LP Cooper Companies, Inc. Transaction History

Centiva Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$315.92 - $397.36 $1.98 Million - $2.5 Million	6,281 New	6,281 $2 Million
Q4 2021 Feb 14, 2022	SELL	$373.53 - $434.12 $895,351 - $1.04 Million	-2,397 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$396.76 - $455.92 $951,033 - $1.09 Million	2,397 New	2,397 $990,000
Q2 2021 Aug 16, 2021	SELL	$372.36 - $412.07 $244,640 - $270,729	-657 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$357.26 - $392.57 $37,155 - $40,827	104 Added 18.81%	657 $252,000
Q4 2020 Feb 16, 2021	BUY	$319.05 - $363.32 $176,434 - $200,915	553 New	553 $201,000

1.23M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.62B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.